X
  • Number
  • FLOSEP-C-014P

Introduction

This product can easily and quickly separate CD14+ mononuclear cells with high purity from fresh or frozen peripheral blood mononuclear cells. The total number of cells that can be treated is 1×10^9, and after purification, more than 85% CD14+ monocytes can be obtained, providing a powerful tool for the use of CD14+ monocytes in basic and clinical research.

Advantage

Easy to operate, only a magnetic pole/cell screen is required to complete the entire operation
Fast operation, only 40 minutes to complete the entire separation operation
Objective The purity of CD14+ monocytes is high, and the purity of CD14+ monocytes can be more than 90%
With high cell yield, more than 90% CD14+ monocytes could be extracted from PBMC
High quality raw materials, the materials used are sterile, mycoplasma free, low endotoxin

Details Document